183 related articles for article (PubMed ID: 32124516)
1. "Everyone needs to understand each other's systems": Stakeholder views on the acceptability and viability of a Pharmacist Independent Prescriber role in care homes for older people in the UK.
Lane K; Bond C; Wright D; Alldred DP; Desborough J; Holland R; Hughes C; Poland F
Health Soc Care Community; 2020 Sep; 28(5):1479-1487. PubMed ID: 32124516
[TBL] [Abstract][Full Text] [Related]
2. Barriers and enablers to deprescribing for older people in care homes: The theory-based perspectives of pharmacist independent prescribers.
Alharthi M; Wright D; Scott S; Birt L
Res Social Adm Pharm; 2023 May; 19(5):746-752. PubMed ID: 36732210
[TBL] [Abstract][Full Text] [Related]
3. The Care Home Independent Prescribing Pharmacist Study (CHIPPS)-a non-randomised feasibility study of independent pharmacist prescribing in care homes.
Inch J; Notman F; Bond CM; Alldred DP; Arthur A; Blyth A; Daffu-O'Reilly A; Ford J; Hughes CM; Maskrey V; Millar A; Myint PK; Poland FM; Shepstone L; Zermansky A; Holland R; Wright D;
Pilot Feasibility Stud; 2019; 5():89. PubMed ID: 31338204
[TBL] [Abstract][Full Text] [Related]
4. Process evaluation for the Care Homes Independent Pharmacist Prescriber Study (CHIPPS).
Birt L; Dalgarno L; Wright DJ; Alharthi M; Inch J; Spargo M; Blacklock J; Poland F; Holland RC; Alldred DP; Hughes CM; Bond CM;
BMC Health Serv Res; 2021 Oct; 21(1):1041. PubMed ID: 34600542
[TBL] [Abstract][Full Text] [Related]
5. Protocol for the process evaluation of a cluster randomised controlled trial to determine the effectiveness and cost-effectiveness of independent pharmacist prescribing in care home: the CHIPPS study.
Bond CM; Holland R; Alldred DP; Arthur A; Barton G; Birt L; Blyth A; Desborough J; Ford J; Handford C; Hill H; Hughes CM; Maskrey V; Massey K; Myint PK; Norris N; Poland FM; Shepstone L; Zermansky A; Wright D;
Trials; 2020 May; 21(1):439. PubMed ID: 32471514
[TBL] [Abstract][Full Text] [Related]
6. What happens when pharmacist independent prescribers lead on medicine management in older people's care homes: a qualitative study.
Birt L; Dalgarno L; Poland F; Wright D; Bond C
BMJ Open; 2023 Oct; 13(10):e068678. PubMed ID: 37907299
[TBL] [Abstract][Full Text] [Related]
7. Protocol for a cluster randomised controlled trial to determine the effectiveness and cost-effectiveness of independent pharmacist prescribing in care homes: the CHIPPS study.
Bond CM; Holland R; Alldred DP; Arthur A; Barton G; Blyth A; Desborough J; Ford J; Handford C; Hill H; Hughes CM; Maskrey V; Massey K; Myint PK; Norris N; Poland FM; Shepstone L; Turner D; Zermansky A; Wright D;
Trials; 2020 Jan; 21(1):103. PubMed ID: 31964398
[TBL] [Abstract][Full Text] [Related]
8. Qualitative analysis of community pharmacists' opinions on their involvement in reducing potentially inappropriate prescribing.
Hansen CR; Byrne S; O'Mahony D; Kearney PM; Sahm LJ
Eur J Clin Pharmacol; 2019 Feb; 75(2):265-274. PubMed ID: 30343483
[TBL] [Abstract][Full Text] [Related]
9. Exploring pharmacy service users' support for and willingness to use community pharmacist prescribing services.
Famiyeh IM; MacKeigan L; Thompson A; Kuluski K; McCarthy LM
Res Social Adm Pharm; 2019 May; 15(5):575-583. PubMed ID: 30100199
[TBL] [Abstract][Full Text] [Related]
10. Development of a clinical pharmacy model within an Australian home nursing service using co-creation and participatory action research: the
Elliott RA; Lee CY; Beanland C; Goeman DP; Petrie N; Petrie B; Vise F; Gray J
BMJ Open; 2017 Nov; 7(11):e018722. PubMed ID: 29102998
[TBL] [Abstract][Full Text] [Related]
11. Stakeholders' views on granting prescribing authority to pharmacists in Nigeria: a qualitative study.
Auta A; Strickland-Hodge B; Maz J
Int J Clin Pharm; 2016 Aug; 38(4):960-7. PubMed ID: 27194098
[TBL] [Abstract][Full Text] [Related]
12. Stakeholders' views of UK nurse and pharmacist supplementary prescribing.
Cooper R; Anderson C; Avery T; Bissell P; Guillaume L; Hutchinson A; Lymn J; Murphy E; Ratcliffe J; Ward P
J Health Serv Res Policy; 2008 Oct; 13(4):215-21. PubMed ID: 18806179
[TBL] [Abstract][Full Text] [Related]
13. A qualitative study of stakeholder views and experiences of minor ailment services in the United Kingdom.
Aly M; García-Cárdenas V; Williams KA; Benrimoj SI
Res Social Adm Pharm; 2019 May; 15(5):496-504. PubMed ID: 29941403
[TBL] [Abstract][Full Text] [Related]
14. Pharmacists in general practice: a qualitative interview case study of stakeholders' experiences in a West London GP federation.
Ryan K; Patel N; Lau WM; Abu-Elmagd H; Stretch G; Pinney H
BMC Health Serv Res; 2018 Apr; 18(1):234. PubMed ID: 29609603
[TBL] [Abstract][Full Text] [Related]
15. Potentially inappropriate prescribing in nursing home residents detected with the community pharmacist specific GheOP(3)S-tool.
Tommelein E; Mehuys E; Petrovic M; Somers A; Van Damme C; Pattyn E; Mattelin K; Boussery K
Int J Clin Pharm; 2016 Oct; 38(5):1063-8. PubMed ID: 27503282
[TBL] [Abstract][Full Text] [Related]
16. Development and feasibility testing of an evidence-based training programme for pharmacist independent prescribers responsible for the medicines-related activities within care homes.
Wright DJ; Blyth A; Maskrey V; Norris N; Bond CM; Hughes CM; Alldred DP; Holland RC;
Int J Pharm Pract; 2021 Aug; 29(4):376-384. PubMed ID: 34018561
[TBL] [Abstract][Full Text] [Related]
17. Examination of England's New Medicine Service (NMS) of complex health care interventions in community pharmacy.
Latif A; Waring J; Watmough D; Barber N; Chuter A; Davies J; Salema NE; Boyd MJ; Elliott RA
Res Social Adm Pharm; 2016; 12(6):966-989. PubMed ID: 26806858
[TBL] [Abstract][Full Text] [Related]
18. Involving the public and other stakeholders in development and evaluation of a community pharmacy alcohol screening and brief advice service.
Krska J; Mackridge AJ
Public Health; 2014 Apr; 128(4):309-16. PubMed ID: 24713598
[TBL] [Abstract][Full Text] [Related]
19. Key stakeholders' views on the potential implementation of pharmacist prescribing: A qualitative investigation.
Jebara T; Cunningham S; MacLure K; Pallivalapila A; Awaisu A; Al Hail M; Stewart D
Res Social Adm Pharm; 2020 Mar; 16(3):405-414. PubMed ID: 31253499
[TBL] [Abstract][Full Text] [Related]
20. Atrial fibrillation screening in pharmacies using an iPhone ECG: a qualitative review of implementation.
Lowres N; Krass I; Neubeck L; Redfern J; McLachlan AJ; Bennett AA; Freedman SB
Int J Clin Pharm; 2015 Dec; 37(6):1111-20. PubMed ID: 26202627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
